The SUSTAIN-6 trial demonstrated a 26% reduction in major adverse cardiovascular events among Type 2 diabetes patients. This wasn't just from improved glycemic control, GLP-1 receptors exist in heart tissue, blood vessels, and kidneys, suggesting direct organ protection
Tsertsvadze A, Fink HA, Yazdi F, MacDonald R, Bella AJ, Ansari MT, et al
We are offering a comprehensive range, backed by our decades of expertise in manufacturing complex medicines
This ensures your financial commitment remains predictable as your prescriber escalates your dose to optimize resultsyour dose may need to go up, but your price won't
The glucose-lowering efficacies of the DPP-4 inhibitors were compared according to the changes in the hemoglobin A1c (HbA1c) levels after 3 months of treatment
($135) ATHLETIC: u Blended for performance, stamina, and recovery + amino acids for muscle building and repair